By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


SIGA Technologies, Inc. 

420 Lexington Avenue
Suite 620
New York  New York  10170  U.S.A.
Phone: 212-672-9100 Fax: 212-697-3130



Gene Therapy

Company News
SIGA (SIGA) Completes Enrollment And Dosing In Final Cohort Of Phase I Study Of IV Formulation Of TPOXX┬« (Tecovirimat) To Treat Smallpox 4/20/2017 8:34:11 AM
SIGA (SIGA) Announces Successful Completion Of Rights Offering; Funding Of Loan; Completion Of Payment Of Pharmathene Obligation 11/17/2016 11:59:36 AM
PharmAthene, Inc. (PIP) Receives Final Payment From SIGA (SIGA) Of $83.9 Million 11/17/2016 8:02:54 AM
SIGA (SIGA) Taps a New CEO 10/13/2016 6:41:48 AM
SIGA (SIGA) Announces Oct. 12 Record Date For Rights Offering 10/10/2016 12:27:40 PM
SIGA (SIGA) Announces Bankruptcy Court Approval Of Transaction Under Which SIGA Will Pay PharmAthene, Inc. (PIP) Claim In Full 9/21/2016 8:59:53 AM
PharmAthene, Inc. (PIP) Announces Receipt Of Payments From SIGA (SIGA) 9/16/2016 6:51:34 AM
SIGA (SIGA) Announces Completion Of Enrollment And Dosing In The Final Cohort Of Phase III Study Of TPOXX (Tecovirimat) 8/30/2016 11:42:18 AM
SIGA (SIGA) Announces Data Safety Monitoring Board (DSMB) Approval To Complete Subject Enrollment In The Final Cohort Of Phase III Study Of TPOXX (Tecovirimat) 8/9/2016 10:23:08 AM
PharmAthene, Inc. (PIP) Receives $20 Million Payment From SIGA (SIGA) To Extend Payment Deadline 7/11/2016 6:27:26 AM